PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Change of Chief Financial Officer, page-13

  1. 118 Posts.
    lightbulb Created with Sketch. 10
    Was he worried about the direction of PAR? If it was good he would never have left. He would have been privy to the latest data. Same as Marco IMO. DYOR.

    Too many part timers and remote workers. This is not professional team managing $80m cash burn, high technology concepts and worth ??? ~ $400m- with poor patent protection. IMO. DYOR.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.